Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMC 1886188)

Published in Am J Pathol on February 01, 1991

Authors

D W Roberts1, T J Bucci, R W Benson, A R Warbritton, T A McRae, N R Pumford, J A Hinson

Author Affiliations

1: Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079-9502.

Articles citing this

Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54

Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos (2009) 1.95

Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int (2011) 1.92

Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res (2013) 1.62

Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol (2015) 1.49

Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48

Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol (2013) 1.46

Current issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products. Life Sci (2011) 1.46

Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase. J Pharmacol Exp Ther (2010) 1.38

Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol (2011) 1.26

SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Rep (2011) 1.22

Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol (2009) 1.10

Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. Eur J Clin Pharmacol (2012) 1.06

Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic Biol Med (2013) 1.05

Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS Open Bio (2014) 1.03

Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem J (2006) 1.02

Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver. Redox Biol (2013) 0.97

Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products. Food Chem Toxicol (2013) 0.96

Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomedicine (2011) 0.95

Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol Appl Pharmacol (1997) 0.91

Acetaminophen hepatotoxicity and HIF-1α induction in acetaminophen toxicity in mice occurs without hypoxia. Toxicol Appl Pharmacol (2011) 0.90

Changes in mouse liver protein glutathionylation after acetaminophen exposure. J Pharmacol Exp Ther (2011) 0.86

Green-tea polyphenols downregulate cyclooxygenase and Bcl-2 activity in acetaminophen-induced hepatotoxicity. Dig Dis Sci (2008) 0.83

Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol (2015) 0.82

The proper use of acetaminophen. Paediatr Child Health (2011) 0.82

Implementation of a standardized pain management in a pediatric surgery unit. Pediatr Surg Int (2010) 0.81

Acylcarnitine profiles in acetaminophen toxicity in the mouse: comparison to toxicity, metabolism and hepatocyte regeneration. Metabolites (2013) 0.81

Effects of combined use of diallyl disulfide and Nacetyl-cysteine on acetaminophen hepatotoxicity in beta-naphthoflavone pretreated mice. World J Gastroenterol (1998) 0.80

Acetaminophen Adducts Detected in Serum of Pediatric Patients With Acute Liver Failure. J Pediatr Gastroenterol Nutr (2015) 0.80

Comparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen Toxicity. PLoS One (2015) 0.80

Correlation of MRI findings to histology of acetaminophen toxicity in the mouse. Magn Reson Imaging (2011) 0.79

Subpopulations of rat hepatocytes separated by Percoll density-gradient centrifugation show characteristics consistent with different acinar locations. Biochem J (1994) 0.78

Chromatin breakdown by deoxyribonuclease1 promotes acetaminophen-induced liver necrosis: an ultrastructural and histochemical study on male CD-1 mice. Histochem Cell Biol (2007) 0.78

Acetaminophen-induced liver damage in mice is associated with gender-specific adduction of peroxiredoxin-6. Redox Biol (2014) 0.78

A novel upregulation of glutathione peroxidase 1 by knockout of liver-regenerating protein Reg3β aggravates acetaminophen-induced hepatic protein nitration. Free Radic Biol Med (2013) 0.75

STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver Damage. Front Immunol (2016) 0.75

Competing Mechanistic Hypotheses of Acetaminophen-Induced Hepatotoxicity Challenged by Virtual Experiments. PLoS Comput Biol (2016) 0.75

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem (1969) 15.62

Acute liver necrosis following overdose of paracetamol. Br Med J (1966) 4.75

Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40

Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet (1971) 4.40

Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89

Liver necrosis from paracetamol. Br J Pharmacol Chemother (1966) 3.77

N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A (1984) 3.09

Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem (1978) 2.18

Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J Pharmacol Exp Ther (1989) 1.28

The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys (1988) 1.17

Drug-induced lipid peroxidation in mice--I. Modulation by monooxygenase activity, glutathione and selenium status. Biochem Pharmacol (1981) 1.15

A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther (1987) 1.13

Commentary. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity. Biochem Pharmacol (1974) 1.12

Antigen preservation in microwave-irradiated tissues: a comparison with formaldehyde fixation. J Pathol (1988) 1.10

The immunologic and metabolic basis of drug hypersensitivities. Annu Rev Pharmacol Toxicol (1988) 1.09

Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. J Med Chem (1982) 1.07

Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test. JAMA (1976) 1.03

Immunochemical detection of acetaminophen-bound liver proteins. Biochem Pharmacol (1987) 0.99

Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetaminophen. Biochem Pharmacol (1990) 0.98

Mechanism of paracetamol toxicity. Lancet (1990) 0.97

Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol Pharmacol (1985) 0.96

Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology (1988) 0.93

Structural characterization of the major covalent adduct formed in vitro between acetaminophen and bovine serum albumin. Chem Biol Interact (1985) 0.91

Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochem Pharmacol (1988) 0.91

Ultrastructural changes during acute acetaminophen-induced hepatotoxicity in the mouse: a time and dose study. Toxicol Pathol (1987) 0.90

3-(glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen. Drug Metab Dispos (1982) 0.89

Metabolic activation and drug toxicity. J Med Chem (1982) 0.89

Ploidy distribution in experimental liver carcinogenesis in mice. Carcinogenesis (1988) 0.88

Immunohistochemical localization of acetaminophen-bound liver proteins. Fundam Appl Toxicol (1989) 0.87

The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase. J Biol Chem (1987) 0.87

Drug-dependent and non-drug-dependent antiplatelet antibody in drug-induced immunologic thrombocytopenic purpura. Blood (1985) 0.82

Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay. J Pharmacol Exp Ther (1989) 0.81

Acetaminophen hypersensitivity resembling Kawasaki disease. Isr J Med Sci (1984) 0.79

Effects of selected chemicals on the glutathione status in the male reproductive system of rats. J Toxicol Environ Health (1990) 0.78

Acute hypersensitivity reactions to paracetamol. Br Med J (Clin Res Ed) (1985) 0.78

Articles by these authors

The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol Pathol (1999) 3.73

Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology (2001) 2.74

Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci (2001) 2.00

Longevity, body weight, and neoplasia in ad libitum-fed and diet-restricted C57BL6 mice fed NIH-31 open formula diet. Toxicol Pathol (1996) 1.69

Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology (1999) 1.68

Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol (1997) 1.66

Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48

Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol (1998) 1.38

Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J Pharmacol Exp Ther (1989) 1.28

Hemodynamic adaptations in the newborn infant. Pediatrics (1965) 1.27

Direct and 18-O-exchange measurements relevant to possible activated or phosphorylated states of myosin. Biochemistry (1966) 1.21

The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys (1988) 1.17

Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity. Nitric Oxide (2001) 1.16

A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther (1987) 1.13

CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci (2000) 1.13

Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology (2000) 1.12

Acetaminophen-induced hepatic glycogen depletion and hyperglycemia in mice. Biochem Pharmacol (1983) 1.12

Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Res (1991) 1.12

Acetaminophen-induced hepatotoxicity. Life Sci (1981) 1.09

Immunochemical detection of oxidized proteins. Chem Res Toxicol (1993) 1.09

Stereoselective formation of bromobenzene glutathione conjugates. Chem Biol Interact (1982) 1.08

Age-related neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice. Toxicol Pathol (1996) 1.04

Covalent binding of xenobiotics to specific proteins in the liver. Drug Metab Rev (1997) 1.03

Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation. Biochem Pharmacol (1977) 1.02

Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod Toxicol (2001) 1.00

Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ Health Perspect (2001) 0.99

Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98

Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicol Appl Pharmacol (1990) 0.98

Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetaminophen. Biochem Pharmacol (1990) 0.98

Mechanism of paracetamol toxicity. Lancet (1990) 0.97

Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophen-treated mice. Toxicol Sci (2000) 0.97

N-Hydroxyacetaminophen: a microsomal metabolite of N-hydroxyphenacetin but apparently not of acetaminophen. Life Sci (1979) 0.96

DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene. Carcinogenesis (2000) 0.96

Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition. J Pharmacol Exp Ther (2000) 0.96

Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology (1995) 0.95

Immunochemical detection of quinol--thioether-derived protein adducts. Chem Res Toxicol (1998) 0.94

Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab Rev (1995) 0.94

The formation of arylating and alkylating metabolites of phenacetin in hamsters and hamster liver microsomes. Mol Pharmacol (1981) 0.94

Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity. Biochem Biophys Res Commun (1994) 0.94

Evaluation of Salmonella-vectored Campylobacter peptide epitopes for reduction of Campylobacter jejuni in broiler chickens. Clin Vaccine Immunol (2010) 0.94

Covalent binding of acetaminophen to N-10-formyltetrahydrofolate dehydrogenase in mice. J Pharmacol Exp Ther (1997) 0.93

Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci (1995) 0.93

Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. Toxicol Lett (1999) 0.93

Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) (2001) 0.91

Trichloroethylene activates CD4+ T cells: potential role in an autoimmune response. Drug Metab Rev (1999) 0.91

Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine. Infect Immun (1979) 0.91

Role of metabolites in propanil-induced hemolytic anemia. Toxicol Appl Pharmacol (1991) 0.91

HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Biochem Biophys Res Commun (1993) 0.91

Ultrastructural changes in myocardium of animals after five months residence at 14,110 feet. Fed Proc (1969) 0.90

Focal degenerative myopathy in turkeys. Avian Dis (1968) 0.90

Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol Sci (2000) 0.90

Reactions of N-acetyl-p-benzoquinone imine with reduced glutathione, acetaminophen, and NADPH. Mol Pharmacol (1986) 0.90

Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia. Adv Exp Med Biol (1991) 0.89

Hepatic necrosis caused by furosemide. Nature (1974) 0.89

Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem Res Toxicol (1996) 0.89

Differential follicle counts as a screen for chemically induced ovarian toxicity in mice: results from continuous breeding bioassays. Fundam Appl Toxicol (1997) 0.89

3-(glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen. Drug Metab Dispos (1982) 0.89

Metabolism of the arylamide herbicide propanil. I. Microsomal metabolism and in vitro methemoglobinemia. Toxicol Appl Pharmacol (1990) 0.89

Acetaminophen-induced hepatotoxicity. Analysis of total covalent binding vs. specific binding to cysteine. Drug Metab Dispos (1996) 0.88

Yeast RNA polymerase III: a zinc metalloenzyme. Biochem Biophys Res Commun (1976) 0.88

A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem Biophys Res Commun (1992) 0.88

A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-alpha but has no activity. Biochem Biophys Res Commun (1991) 0.88

Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol Appl Pharmacol (2000) 0.87

Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat. Environ Health Perspect (2001) 0.87

Reaction of mutagenic phenacetin metabolites with glutathione and DNA. Possible implications for toxicity. Mol Pharmacol (1984) 0.87

Bromobenzene and p-bromophenol toxicity and covalent binding in vivo. Life Sci (1982) 0.87

The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase. J Biol Chem (1987) 0.87

Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin. Mol Pharmacol (1977) 0.86

Comparison of covalent binding of acetaminophen and the regioisomer 3'-hydroxyacetanilide to mouse liver protein. Toxicol Lett (1997) 0.86

Immunological homology among azoreductases from Clostridium and Eubacterium strains isolated from human intestinal microflora. J Basic Microbiol (1992) 0.86

Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. Chem Res Toxicol (1996) 0.86

Hapten carrier conjugates associated with halothane hepatitis. Adv Exp Med Biol (1991) 0.85

Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem Res Toxicol (1995) 0.85

Saccharomyces cerevisiae DNA-dependent RNA polymerase III: a zinc metalloenzyme. Biochemistry (1978) 0.85

Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res (1989) 0.85

Tonsillomycosis: a myco-histopathological study. J Laryngol Otol (1982) 0.85

Intestinal response to 1 alpha, 25-dihydroxycholecalciferol. I. RNA polymerase, alkaline phosphatase, calcium and phosphorus uptake in vitro, and in vivo calcium transport and accumulation. Biochim Biophys Acta (1978) 0.84

Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther (2001) 0.84

Conversion of the N-Q-glucuronide and N-O-sulfate conjugates of N-hydroxyphenacetin to reactive intermediates. Biochem Pharmacol (1978) 0.84